Diabetic hyperglycemia is associated with the severity of epileptic seizures in adults

Epilepsy Research

Volumn 79, Issue 1, 2008, Pages 71-77

  Huang, Chin Wei ^a   Tsai, Jing Jane ^a   Ou, Horng Yih ^a   Wang, Shin Tair ^a   Cheng, Juei Tang ^a   Wu, Sheng Nan ^a   Huang, Chao Ching ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Diabetic hyperglycemia; Epileptic seizures; Severity

Indexed keywords

CARBAMAZEPINE; PHENYTOIN; VALPROIC ACID;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRAND MAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MYOCLONUS SEIZURE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS; EPILEPSY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 40349088817     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2007.12.012     Document Type: Article

References (36)

1. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 29 (2006) S43-S48
2. Beamer N., Giraud G., Clark W., Wynn M., and Coull B. Diabetes, hypertension and erythrocyte aggregation in acute stroke. Cerebrovasc. Dis. 7 (1997) 144-149
3. Brick J.F., Gutrecht J.A., and Ringel R.A. Reflex epilepsy and nonketotic hyperglycemia in the elderly: a specific neuroendocrine syndrome. Neurology 39 (1989) 394-399
4. Commission on the Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22 (1981) 489-501
5. Duckrow R.B. Decreased cerebral blood flow during acute hyperglycemia. Brain Res. 703 (1995) 145-150
6. Finch C.E., and Cohen D.M. Aging, metabolism and Alzheimer disease: review and hypotheses. Exp. Neurol. 143 (1997) 82-102
7. Gispen W.H., and Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 23 (2000) 542-549
8. Grant C., and Warlow C. Focal epilepsy in diabetic non-ketotic hyperglycaemia. Br. Med. J. 290 (1985) 1204-1205
9. Groeneveld Y., Petri H., Hermans J., and Springer M.P. Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review. Diabet. Med. 16 (1999) 2-13
10. Harden C.L., Rosenbaum D.H., and Daras M. Hyperglycemia presenting with occipital seizures. Epilepsia 32 (1991) 215-220
11. Haut S.R., Shinnar S., and Moshe S.L. Seizure clustering: risks and outcomes. Epilepsia 46 (2005) 146-149
12. Huang C.W., Hsieh Y.J., Pai M.C., Tsai J.J., and Huang C.C. Non-ketotic hyperglycemia-related epilepsia partialis continua with ictal unilateral parietal hyperperfusion. Epilepsia 46 (2005) 1843-1844
13. Huang C.W., Hsieh Y.J., Huang C.C., and Tsai J.J. Non-ketotic hyperglycemia-related paroxysmal bilateral hand paresthesia misdiagnosed as diabetic neuropathy. Neurol. Sci. 27 (2006) 180-182
14. Huang C.W., Huang C.C., Cheng J.T., Tsai J.J., and Wu S.N. Glucose and hippocampal neuronal excitability: the role of ATP-sensitive potassium channels. J. Neurosci. Res. 85 (2007) 1468-1477
15. Lavin P.J. Hyperglycemic hemianopia: a reversible complication of non-ketotic hyperglycemia. Neurology 65 (2005) 616-619
16. Loeb J.N. The hyperosmolar state. N. Engl. J. Med. 290 (1974) 1184-1187
17. Maccario M., Messis C.P., and Vastola E.F. Focal seizures as a manifestation of hyperglycemia without ketoacidosis. Neurology 15 (1965) 195-206
18. Monnier L., Mas E., Ginet C., Michel F., Villon L., Cristol J.P., and Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006) 1681-1687
19. Murray A.D., Staff R.T., Shenkin S.D., Deary I.J., Starr J.M., and Whalley L.J. Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Radiology 237 (2005) 251-257
20. Nathan D.M., Cleary P.A., Backlund J.Y., Genuth S.M., Lachin J.M., Orchard T.J., Raskin P., Zinman B., and Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353 (2005) 2643-2653
21. Pelligrino D.A., LaManna J.C., Duckrow R.B., Bryan Jr. R.M., and Harik S.I. Hyperglycemia and blood-brain barrier glucose transport. J. Cereb. Blood Flow Metab. 12 (1992) 887-899
22. Peterson K.P., Pavlovich J.G., Goldstein D., Little R., England J., and Peterson C.M. What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. Clin. Chem. 44 (1998) 1951-1958
23. Priel M.R., Bortolotto Z.A., and Cavalheiro E.A. Effects of systemic glucose injection on the development of amygdala kindling in rats. Behav. Neural. Biol. 56 (1991) 314-318
24. Reynolds K., and He J. Epidemiology of the metabolic syndrome. Am. J. Med. Sci. 330 (2005) 273-279
25. Saaddine J.B., Cadwell B., Gregg E.W., Engelgau M.M., Vinicor F., Imperatore G., and Narayan K.M. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann. Intern. Med. 144 (2006) 465-474
26. Schwechter E.M., Veliskova J., and Velisek L. Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann. Neurol. 53 (2003) 91-101
27. Singh B.M., and Strobos R.J. Epilepsia partialis continua associated with nonketotic hyperglycemia: clinical and biochemical profile of 21 patients. Ann. Neurol. 8 (1989) 155-160
28. Stafstrom C.E. Hyperglycemia lowers seizure threshold. Epilepsy Curr. 3 (2003) 148-149
29. Starr J.M., Wardlaw J., Ferguson K., Mac-Lullich A., Deary I.J., and Marshall I. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry 74 (2003) 70-76
30. Tesfaye S., Chaturvedi N., Eaton S.E., Ward J.D., Manes C., Ionescu-Tirgoviste C., Witte D.R., Fuller J.H., and EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N. Engl. J. Med. 352 (2005) 341-350
31. Tiamkao S., Pratipanawatr T., Tiamkao S., Nitinavakarn B., Chotmongkol V., and Jitpimolmard S. Seizures in nonketotic hyperglycaemia. Seizure 12 (2003) 409-410
32. Tutka P., Sawiniec J., and Kleinrok Z. Experimental diabetes sensitizes mice to electrical- and bicuculline-induced convulsions. Pol. J. Pharmacol. 50 (1998) 92-93
33. Venna N., and Sabin T.D. Tonic fecal seizures in nonketotic hyperglycemia of diabetes mellitus. Arch. Neurol. 38 (1981) 512-514
34. Weiss R., Dziura J., Burgert T.S., Tamborlane W.V., Taksali S.E., Yeckel C.W., Allen K., Lopes M., Savoye M., Morrison J., Sherwin R.S., and Caprio S. Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med. 350 (2004) 2362-2374
35. White H.S., Woodbury D.M., Chen C.F., Kemp J.W., Chow S.Y., and Yen-Chow Y.C. Role of glial cation and anion transport mechanisms in etiology and arrest of seizures. Adv. Neurol. 44 (1986) 695-712
36. Writing Team for the Diabetes Control Complications Trial/Epidemiology of Diabetes Interventions Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287 (2002) 2563-2569